Pharmazeutische Zeitung onlineMS: Neue Therapeutika in SichtPharmazeutische Zeitung onlineDaclizumab, das bereits als Immunsuppressivum nach Organtransplantation auf dem Markt war, richtet sich gegen CD25-Proteine am Interleukin-2-Rezeptor und beeinflu…
Hep C Cure Costs Pose Challenge for MedicareMedPage Today5/1/2014. |. 9. CME 66 taken. MERS Surge: Many Questions, Few Answers. 5/6/2014. |. 2. CME 56 taken. Antipsychotics Linked to Less Violent Crime. 5/7/2014. |. 5. CME 42 taken. RheumShorts: Methot…
RheumShorts: Methotrexate, Basiliximab, and Norwegian LymeMedPage TodayIncreases in the soluble interleukin-2 receptor (CD25) have been identified in patients with autoimmune diseases such as systemic sclerosis, and a recent open-label study found bene…
|
Company Update (NASDAQ:BIIB): Biogen Idec Signs License Agreement With …
Jutia Group Its products under Phase III clinical trials consist of Daclizumab, a monoclonal antibody in relapsing MS; TYSABRI for secondary progressive MS; and GA101, a monoclonal antibody for chronic lymphocytic leukemia and NHL. The company’s Phase II clinical … |
MedPage TodayRisk Score Predicts Arthritis ProgressionMedPage Today4/16/2014. |. 5. CME 48 taken. Smoking Tied to Worse Lupus, Arthritis. 4/13/2014. |. 0. CME 41 taken. RheumShorts: Methotrexate, Basiliximab, and Norwegian Lyme. 4/21/2014. |. 2. CME 40…
Treat-to-Target the New Goal in LupusMedPage Today4/16/2014. |. 5. CME 50 taken. Low Back Pain Afflicts Millions Around the World. 3/25/2014. |. 12. CME 48 taken. Smoking Tied to Worse Lupus, Arthritis. 4/13/2014. |. 0. CME 41 taken. RheumShorts: Metho…
|
AbbVie Candidate in Pivotal Study – Analyst Blog
NASDAQ AbbVie and Biogen are developing daclizumab for relapsing remitting multiple sclerosis (regulatory applications slated for late 2014). AbbVie’s Duopa is under review in the U.S. for advanced Parkinson’s disease. Meanwhile, veliparib is in another phase … |
MedPage TodayAlcohol Use Lowers RA Risk in WomenMedPage TodayChinese Herb Proves Effective in RA. 4/15/2014. |. 5. CME 52 taken. Where Does RA Start? 4/16/2014. |. 5. CME 45 taken. Smoking Tied to Worse Lupus, Arthritis. 4/13/2014. |. 0. CME 38 taken. …
|
AbbVie Candidate in Pivotal Study
Zacks.com AbbVie and Biogen are developing daclizumab for relapsing remitting multiple sclerosis (regulatory applications slated for late 2014). AbbVie’s Duopa is under review in the U.S. for advanced Parkinson’s disease. Meanwhile, veliparib is in another phase … |
MedPage TodayChinese Herb Proves Effective in RAMedPage TodayChinese Herb Proves Effective in RA. 4/15/2014. |. 5. CME 52 taken. Where Does RA Start? 4/16/2014. |. 5. CME 45 taken. Smoking Tied to Worse Lupus, Arthritis. 4/13/2014. |. 0. CME 38 taken. …